Back to Market返回行情

WAT Waters Corporation

USHealthcare
$377.13+2.44%ClosedMarket Cap: $24.58B

As of 2026-07-09 16:00

Why WAT matters now

Waters Corporation (WAT) is a US stock in Healthcare. The latest InvestLog snapshot shows $377.13 with +2.44% on the session and $24.58B in market capitalization; recent performance reads 1-month +6.66% and YTD -6.42%.

The latest financial table shown here is Q1 2026, with revenue of $1.27B, net income of $-72.0M, and EPS of $-0.87. Investors can compare that operating picture with valuation signals such as P/E 28.46 and FCF yield 1.1%.

The latest indexable market news headline is "Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call" from PRNewsWire.

Additional event context on this page matters because analyst consensus is Buy with a median target of $393.50; recent insider activity includes Chaubal Amol filing F-InKind; recent congressional disclosure data includes Ro Khanna Purchase. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

28.46

PEG

37.86

P/B

1.91

P/S

6.14

EV/EBITDA

30.59

DCF Value

$235.79

FCF Yield

1.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

55.0%

Operating Margin

17.1%

Net Margin

11.9%

ROE

8.0%

ROA

1.8%

ROIC

2.4%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$1.27B$-72.0M$-0.87
Q4 2025$932.4M$225.2M$3.77
FY 2025$3.17B$642.6M$10.76
Q3 2025$799.9M$148.9M$2.50

Analyst Ratings

Consensus

Buy

Target (Consensus)

$395.25

Target (Median)

$393.50

Target Range

$350.00 - $440.00

Strong Buy: 2Buy: 12Hold: 9Sell: 0Strong Sell: 0
HSBCBuy
2026-06-03
B of A SecuritiesNeutral
2026-06-02
Wells FargoEqual Weight
2026-05-14
BarclaysOverweight
2026-05-07
TD CowenHold
2026-05-06

Trading Activity

Insider Trades

Chaubal Amolofficer: SVP & Chief Financial Officer
Sell2026-05-14
Bennett Jianqingofficer: SVP Waters Adv. Diagnostics
Sell2026-04-07
Knight Heatherdirector
Sell2026-04-02
Jiang Weidirector
Sell2026-04-02
Jiang Weidirector
Buy2026-03-18

Congress Trades

Ro KhannaBuy
2026-05-13
Thomas H. KeanSell
2026-04-14
Thomas H. KeanSell
2026-03-18

Company Info

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

US

Exchange

Beta

1.20

Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.